ES459263A1 - Procedimiento y dispositivo para la preparacion de productosde coagulacion sanguinea filtrados en condiciones esteriles. - Google Patents

Procedimiento y dispositivo para la preparacion de productosde coagulacion sanguinea filtrados en condiciones esteriles.

Info

Publication number
ES459263A1
ES459263A1 ES459263A ES459263A ES459263A1 ES 459263 A1 ES459263 A1 ES 459263A1 ES 459263 A ES459263 A ES 459263A ES 459263 A ES459263 A ES 459263A ES 459263 A1 ES459263 A1 ES 459263A1
Authority
ES
Spain
Prior art keywords
cryo
precipitate
sterile filtered
plasma
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES459263A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARNOLD SEUFERT DR MED DR RER N
Original Assignee
ARNOLD SEUFERT DR MED DR RER N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARNOLD SEUFERT DR MED DR RER N filed Critical ARNOLD SEUFERT DR MED DR RER N
Publication of ES459263A1 publication Critical patent/ES459263A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES459263A 1976-05-31 1977-05-28 Procedimiento y dispositivo para la preparacion de productosde coagulacion sanguinea filtrados en condiciones esteriles. Expired ES459263A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2624373A DE2624373C2 (de) 1976-05-31 1976-05-31 Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII

Publications (1)

Publication Number Publication Date
ES459263A1 true ES459263A1 (es) 1978-03-16

Family

ID=5979428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES459263A Expired ES459263A1 (es) 1976-05-31 1977-05-28 Procedimiento y dispositivo para la preparacion de productosde coagulacion sanguinea filtrados en condiciones esteriles.

Country Status (16)

Country Link
US (1) US4141887A (enExample)
JP (1) JPS52148610A (enExample)
AT (1) AT361123B (enExample)
AU (1) AU514223B2 (enExample)
BE (1) BE855187A (enExample)
CA (1) CA1088424A (enExample)
CH (1) CH626252A5 (enExample)
DD (1) DD131452A5 (enExample)
DE (1) DE2624373C2 (enExample)
ES (1) ES459263A1 (enExample)
FR (1) FR2353298A1 (enExample)
GB (1) GB1571202A (enExample)
IT (1) IT1082422B (enExample)
NL (1) NL7705655A (enExample)
SE (1) SE444646B (enExample)
ZA (1) ZA773208B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278592A (en) * 1979-03-30 1981-07-14 Arnold Seufert Process and apparatus for the production of sterile filtered blood clotting factors
AT369263B (de) 1980-08-27 1982-12-27 Immuno Ag Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
DE3210444A1 (de) * 1981-04-02 1982-11-11 National Research Development Corp., London Verfahren und vorrichtung zur behandlung von blutplasma
IN161706B (enExample) * 1983-10-05 1988-01-16 Solco Basel Ag
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US4915847A (en) * 1987-08-04 1990-04-10 Baxter International Inc. Cryoglobulin separation
US4917804A (en) * 1986-10-31 1990-04-17 Baxter International Inc. Method and vessel for separation of cryoglobin
NO874882L (no) * 1987-11-24 1989-05-25 Fasting Biotech As Fremgangsmaate ved konsentrering av faktor viii.
NL9000090A (nl) * 1990-01-15 1991-08-01 Harimex Ligos Bv Werkwijze voor het bereiden van een fibrinogeenconcentraat uit bloedplasma, inrichting voor het uitvoeren van deze werkwijze en werkwijze voor het bereiden van fibrinogeen uit het concentraat.
DK119490D0 (da) * 1990-05-14 1990-05-14 Unes As Apparat til fremstilling af et koncentrat af koagulationsfaktorer, saasom fibrinogen, fra en blodportion
DK167517B1 (da) * 1991-11-11 1993-11-15 Squibb & Sons Inc Beholder til optagelse og adskillelse af en vaeske, fortrinsvis blodplasma, i dennes bestanddele
DE4143639C2 (de) * 1991-12-02 2002-10-24 Qiagen Gmbh Verfahren zur Isolierung und Reinigung von Nukleinsäuren
US5520885A (en) * 1993-01-19 1996-05-28 Thermogenesis Corporation Fibrinogen processing apparatus, method and container
ZA948564B (en) * 1993-11-19 1995-07-26 Bristol Myers Squibb Co Liquid separation apparatus and method
HUT77810A (hu) * 1994-12-02 1998-08-28 Bristol-Myers Squibb Company Berendezés és eljárás, valamint centrifuga-reagens ellátó redszer egy komponens elválasztására plazmából
ATE405335T1 (de) * 1994-12-02 2008-09-15 Vivolution As Methode und vorrichtung zum abtrennen von fibrinmonomer aus blutplasma
US5733446A (en) * 1994-12-02 1998-03-31 Bristol-Myers Squibb Company Centrifuge with annular filter
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
AU784808B2 (en) * 2001-04-02 2006-06-29 Kedrion Melville Inc. Prion and viral clearance process
ATE555666T1 (de) * 2002-05-23 2012-05-15 Ortho Clinical Diagnostics Inc Einfang, konzentration und quantifizierung eines abnormalen prionproteins aus biologischen flüssigkeiten mittels tiefenfiltration
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
CA2709781C (en) 2007-12-28 2017-03-14 Baxter International Inc. Counter-pressure filtration of proteins
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
AU2015217275B2 (en) 2014-02-14 2019-11-21 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles
CN105481939A (zh) * 2015-12-28 2016-04-13 武汉中原瑞德生物制品有限责任公司 用于处理冷沉淀的装置以及制备冷沉淀的方法
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP7541993B2 (ja) 2019-03-14 2024-08-29 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥用ローディングトレイ組立体、凍結乾燥システム及び凍結乾燥方法
CN114366840B (zh) * 2022-01-12 2023-06-09 山东中保康医疗器具有限公司 基于血袋管理的病毒灭活装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2521121A (en) * 1943-09-29 1950-09-05 Kilpatrick Martin Dispersion separation
US2543808A (en) * 1946-12-26 1951-03-06 Parke Davis & Co Method of preparing fibrinogen
US2864506A (en) * 1953-11-30 1958-12-16 Clarence F Hiskey Device for ultrafiltration
US3005556A (en) * 1957-08-19 1961-10-24 Jensen Carl Christian Filter
US3145713A (en) * 1963-09-12 1964-08-25 Protein Foundation Inc Method and apparatus for processing blood
US3449314A (en) * 1966-06-03 1969-06-10 Ortho Pharma Corp Preparation of anti-rh globulin from human plasma
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3560377A (en) * 1969-01-21 1971-02-02 Amicon Corp Apparatus and process for filtering fluids
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
GB1507198A (en) * 1974-04-12 1978-04-12 Squibb & Sons Inc Antihemophilic factor
FR2283700A1 (fr) * 1974-09-03 1976-04-02 Baxter Laboratories Inc Appareil et procede de separation du cryoprecipite du plasma sanguin
IL47945A (en) * 1974-09-03 1977-08-31 Baxter Travenol Lab Method and apparatus for the separation of cryprecipitate separation of cryoprecipitate from blood plasma
US4025618A (en) * 1974-09-03 1977-05-24 Baxter Travenol Laboratories, Inc. Method for separation of cryoprecipitate from blook plasma

Also Published As

Publication number Publication date
CH626252A5 (enExample) 1981-11-13
FR2353298B1 (enExample) 1982-06-18
FR2353298A1 (fr) 1977-12-30
ZA773208B (en) 1978-05-30
GB1571202A (en) 1980-07-09
SE7706272L (sv) 1977-12-01
SE444646B (sv) 1986-04-28
DE2624373C2 (de) 1983-02-03
BE855187A (fr) 1977-09-16
DD131452A5 (de) 1978-06-28
US4141887A (en) 1979-02-27
AT361123B (de) 1981-02-25
DE2624373A1 (de) 1977-12-08
CA1088424A (en) 1980-10-28
NL7705655A (nl) 1977-12-02
IT1082422B (it) 1985-05-21
AU2566277A (en) 1978-12-07
AU514223B2 (en) 1981-01-29
ATA324477A (de) 1980-07-15
JPS52148610A (en) 1977-12-10

Similar Documents

Publication Publication Date Title
ES459263A1 (es) Procedimiento y dispositivo para la preparacion de productosde coagulacion sanguinea filtrados en condiciones esteriles.
UA5996A1 (uk) Спосіб одержання панкреотину з підшлункової залози
UA26192C2 (uk) Спосіб одержаhhя очищеhої терефталевої кислоти
ES2002613T5 (es) Modulo de flotacion a presion y metodo para la separacion de la espuma a presion no atmosferica.
GB1104497A (en) Recovery of spent etchants
FI103510B1 (fi) Menetelmä tekijän VIII eristämiseksi
GB1492724A (en) Method of producing a non-fibrous pancreatin having a low germ count
Ahkong et al. Proteinases and cell fusion
ES457663A1 (es) Un metodo de produccion de un paquete impermeable a los ga- ses.
JPS55114301A (en) Improved counterrcurrent crystallizing method
JPS5689802A (en) Method of concentrating aqueous solution of temperature sensitive substance
ES8103185A1 (es) Un metodo para concentrar un material que contiene uranio y calcio en solucion
ES405938A1 (es) Procedimiento para el aislamiento de material tromboplasti-co.
GB1516698A (en) Apparatus and method for separation of cryoprecipitate from blood plasma
ES457482A1 (es) Metodo para la obtencion de inmunoglobulina.
BE798647A (fr) Procede de separation du gaz carbonique et/ou de l'hydrogene sulfure et autres gaz acides.
ATE58753T1 (de) Gewebekultur, zellenvermehrungsfoerdernde stoffe, verfahren zur herstellung und verwendung.
GB1112598A (en) Method for concentrating aqueous solutions
EP0239335A3 (en) Non-inflammatory hyaluronic acid fraction and process for preparing it
DE3585416D1 (de) Verfahren zur herstellung eines biologischen stoffes.
ES443499A1 (es) Procedimiento para la obtencion simultanea de insulina juntocon pancreatina a partir de pancreas de animales de ganado porcino.
GB1293795A (en) Improvements relating to anticoagulants
GB1288168A (enExample)
ATE132875T1 (de) Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung
JPS57179123A (en) Purification of number viii factor-containing aqueous solution

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971103